A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Public ClinicalTrials.gov record NCT01500200. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Study identification
- NCT ID
- NCT01500200
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Alkermes, Inc.
- Industry
- Enrollment
- 142 participants
Conditions and interventions
Conditions
Interventions
- ALKS 5461 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2011
- Primary completion
- Feb 28, 2013
- Completion
- Feb 28, 2013
- Last update posted
- May 20, 2019
2011 – 2013
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alkermes Investigational Site | Tucson | Arizona | 85712 | — |
| Alkermes Investigational Site | Oceanside | California | 92056 | — |
| Alkermes Investigational Site | Santa Ana | California | 92701 | — |
| Alkermes Investigational Site | Torrance | California | 90502 | — |
| Alkermes Investigational Site | Fort Myers | Florida | 33912 | — |
| Alkermes Investigational Site | Lauderhill | Florida | 33319 | — |
| Alkermes Investigational Site | Leesburg | Florida | 34748 | — |
| Alkermes Investigational Site | North Miami | Florida | 33161 | — |
| Alkermes Investigational Site | St. Petersburg | Florida | 33716 | — |
| Alkermes Investigational Site | Atlanta | Georgia | 30308 | — |
| Alkermes Investigational Site | Hoffman Estates | Illinois | 60169 | — |
| Alkermes Investigational Site | Baltimore | Maryland | 21285 | — |
| Alkermes Investigational Site | Boston | Massachusetts | 02135 | — |
| Alkermes Investigational Site | Haverhill | Massachusetts | 01830 | — |
| Alkermes Investigational Site | Berlin | New Jersey | 08009 | — |
| Alkermes Investigational Site | Brooklyn | New York | 11241 | — |
| Alkermes Investigational Site | New York | New York | 10021 | — |
| Alkermes Investigational Site | Canton | Ohio | 44718 | — |
| Alkermes Investigational Site | Dayton | Ohio | 45417 | — |
| Alkermes Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Alkermes Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Alkermes Investigational Site | Charleston | South Carolina | 29407 | — |
| Alkermes Investigational Site | Austin | Texas | 78754 | — |
| Alkermes Investigational Site | Dallas | Texas | 75235 | — |
| Alkermes Investigational Site | Houston | Texas | 77081 | — |
| Alkermes Investigational Site | San Antonio | Texas | 78229 | — |
| Alkermes Investigational Site | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01500200, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 20, 2019 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01500200 live on ClinicalTrials.gov.